0001127602-24-016175.txt : 20240521 0001127602-24-016175.hdr.sgml : 20240521 20240521180156 ACCESSION NUMBER: 0001127602-24-016175 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240517 FILED AS OF DATE: 20240521 DATE AS OF CHANGE: 20240521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Strong Stewart W CENTRAL INDEX KEY: 0001420910 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 24971060 MAIL ADDRESS: STREET 1: C/O HAEMONETICS CORPORATION STREET 2: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0330 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-05-17 0000313143 HAEMONETICS CORP HAE 0001420910 Strong Stewart W 125 SUMMER STREET BOSTON MA 02110 1 President, Global Hospital 1 Common Stock 2024-05-17 4 F 0 284 95.73 D 15324 D Common Stock 2024-05-17 4 A 0 2872 A 18196 D Common Stock 2024-05-20 4 M 0 2241 56.57 A 20437 D Common Stock 2024-05-20 4 F 0 1555 95.08 D 18882 D Common Stock 2024-05-20 4 S 0 686 95.11 D 18196 D Non-qualified Stock Option (Right to Buy) 95.73 2024-05-17 4 A 0 6313 0 A 2031-05-17 Common Stock 6313 6313 D Non-qualified Stock Option (Right to Buy) 56.57 2024-05-20 4 M 0 2241 0 D 2023-05-18 2028-05-18 Common Stock 2241 2242 D Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I. This number includes unvested RSUs previously reported. The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Transaction pursuant to an existing 10b5-1 trading plan dated June 12, 2023 (fully executed as of June 12, 2023). Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I. Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Reflects options granted on May 18, 2021 that vest in annual increments of 25% beginning on the first anniversary of the date of grant. /s/ Thomas V. Powers, attorney-in-fact for Mr. Strong 2024-05-21